Chris@CNW, Author at CannabisNewsWire

WednesdaySep 20, 2023 4:20 pm

420 with CNW — Twist of Fate? DEA Now Tasked with Steering Marijuana Rescheduling

The United States is on the brink of a groundbreaking shift in its approach to marijuana policy. However, a significant obstacle stands in the way of this reform: the Drug Enforcement Administration (DEA). Recognizing marijuana’s medical value, the U.S. Department of Health and Human Services ( HHS) recommended reclassifying marijuana as a Schedule III controlled substance in response to President Joe Biden's call for a comprehensive review of marijuana scheduling last year. This pivotal moment in federal government policy places the key marijuana decision in the hands of the DEA, an agency historically associated with the country's war on drugs.…

WednesdaySep 20, 2023 4:20 am

420 with CNW — Marijuana ETFs See Green as Hopes for Federal Marijuana-Policy Reform Rise

Cannabis Exchange-Traded Funds (ETFs) surged in value in September as positive federal action renewed investor interest in the cannabis industry. Shortly after the U.S. Department of Health and Human Services recommended that the Drug Enforcement Administration (DEA) reclassify cannabis to Schedule III from Schedule I and ease federal marijuana restrictions, marijuana-related ETFs began to soar as investors started investing in the cannabis industry. America’s state-legal cannabis sector is the fastest-growing sector in the nation, generating billions of dollars in yearly revenue. However, the industry has been consistently handicapped by federal regulation. Federal law still classifies cannabis as a Schedule I…

TuesdaySep 19, 2023 4:20 pm

420 with CNW — Caribbean, Latam Nations Agree War on Drugs Has Failed, New Solutions Needed

A coalition of 19 Caribbean and Latin American nations has jointly released a statement, underscoring the imperative need for a reevaluation of global drug policies. In a conference held over the weekend, these countries expressed their dissatisfaction with the current punitive strategy for combating the global drug issue, noting that it has failed to yield the desired results and has often exacerbated underlying problems while exploiting the vulnerabilities of their societies and territories. The statement received support from representatives of numerous nations, including Brazil, Uruguay, Nicaragua, Colombia, Guatemala, El Salvador, Panama, Venezuela, Chile, Bolivia, Cuba, Honduras, Ecuador, Costa Rica, Peru,…

TuesdaySep 19, 2023 4:20 am

420 with CNW — Cannabis Rescheduling Recommendation Far Below Biden’s Campaign Promises, Advocates Say

Nearly two years after President Joe Biden took office, policy experts and drug-reform advocates aren’t happy with the Biden administration’s efforts to fulfill the campaign’s cannabis promises. Last month, the Biden administration recommended that the U.S. Drug Enforcement Administration (DEA) reclassify marijuana and asked federal drug officials to consider removing the decades-long restrictions on marijuana. The Department of Health and Human Services (HHS) issued the cannabis rescheduling recommendation to the DEA after President Biden sent a request to the HHS calling for a review of the rescheduling of marijuana as a Schedule I drug with no medical application. Schedule III…

MondaySep 18, 2023 4:20 pm

420 with CNW — Study Shows Users of Medical Cannabis Register Improvements in Depression, Anxiety and Pain

A recent study in the "PLoS ONE" journal found that more than 2,300 individuals with persistent health issues experienced improved well-being and reduced fatigue within the first three months of using medicinal cannabis. The study was centered on the responses obtained from eligible Australian patients who participated in the QUEST Initiative. The participants' age spectrum spanned from 18 to 97 years of age, with an average age of 51. Among the participants, 62.8% were women while 37.2% were men. The majority of participants reported experiencing chronic pain (69%), followed by insomnia (23%), anxiety (22%), and a combination of anxiety and…

MondaySep 18, 2023 10:30 am

420 Expo 2023: Celebrating the Cannabis Culture

Cannabis enthusiasts, investors, decision-makers, and business owners, are invited to attend the 420 Expo 2023 to be held in New Jersey Expo Center, Edison, NJ from September 29 – October 1, 2023. The electrifying event is set to blaze the ever-evolving cannabis landscape, including medical experts discussing the therapeutic potential of cannabis and professionals sharing their success stories. 420 Expo 2023 is a one-of-a-kind gathering that celebrates the world of cannabis culture, from its insightful medical applications to its important role in mainstream culture. Featuring the legendary Cheech Marin as a special guest host, the dynamic cannabis convergence promises to…

MondaySep 18, 2023 4:20 am

420 with CNW — California Senate OKs Marijuana Cafes Bill

The California senate has passed a marijuana cafe bill that would give dispensaries permission to provide noncannabis drinks and foods to customers who have approval from local authorities. State senators passed Assemblymember Matt Haney’s Bill AB 374 in a 33 to 3 vote before sending it back to the assembly for a concurrence vote thanks to slight amendments made in a Senate committee. If the assembly votes in favor of the amended cannabis cafe bill, it could head to California Governor Gavin Newsom’s desk for his signature. The marijuana consumption cafe bill would grant local governments the authority to allow…

FridaySep 15, 2023 4:20 pm

420 with CNW — Israel, Australia Ranked as Top Importers of Canadian Medical Marijuana

New data from Health Canada has revealed that Australia and Israel were the top buyers of Canada’s medical marijuana exports in 2022. Figures shared through MJBizDaily show that the two nations were the largest markets for Canadian medical cannabis importers amid a surge in cannabis exports from Canada. Medical cannabis flower exports from the North American nation totaled around 132,200 pounds for fiscal year April 2022 through March 2023 and went up by 48% from the previous fiscal year’s roughly 90,000 pounds. Close to 80% of medical marijuana flower exports from Canada (104,000 pounds) went to Australia and Israel and…

FridaySep 15, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria’s IND application for its U.S. Phase 1b Hypertension Clinical Study, HYPER-H23-1, remains on track despite setbacks Work mostly under Lexaria’s control was completed earlier this year, while work that is outside its control remains delayed Regardless, Lexaria continues to make progress, even as it looks to take advantage of the growing global cardiovascular drugs market, which is projected to post a CAGR of 3.1% between 2021 and 2026 Chris Bunka, Lexaria’s CEO, has lauded the company’s exceptional discovery, which demonstrates the ability of the patented DehydraTECH-processed CBD to lower blood pressure in the patient population Lexaria Bioscience (NASDAQ: LEXX),…

FridaySep 15, 2023 4:20 am

420 with CNW — Data Shows Border Sales Boosting Retailers’ Earnings in US

Marijuana sales crossing state lines have proven to be a lucrative source of revenue for retailers in the United States, and recent data suggests that a similar trend is emerging along international borders, particularly with Mexico. Insights gathered from various sources, including LeafLink, quarterly reports, state agencies and interviews with marijuana companies, support this observation. LeafLink’s analysis of numerous ZIP codes found that when new recreational marijuana markets open, retailers near state borders tend to increase their inventory orders significantly compared to those located further inland. Over the past three years, wholesale cannabis product purchases by border stores surged by…